Exome Asset Management LLC

Q2 2026 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
52
Total value ($000)
$162,102
Net value change ($000)
-31,243 (-16.2%)
New positions
15
Sold out positions
8
Turnover %
31.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
TGTX 9,060 NEW
ABVX 6,247 NEW
QURE 3,733 NEW
GH 2,485 32.5%
AZN 2,254 NEW
VKTX 1,867 NEW
OCUL 1,783 NEW
EQ 1,769 NEW
Ascendis Pharma AS 1,753 NEW
NKTR 1,565 NEW
Top Reduces (Value $000, Stocks/ETFs)
PRAX -5,542 -37.8%
ELV -4,297 -100.0%
BBIO -3,645 -72.7%
ELVN -3,543 -41.1%
APLS -3,440 -100.0%
INSM -2,879 -66.1%
COGT -2,574 -24.0%
AVTX -2,379 -100.0%
SLNO -2,065 -100.0%
RLAY -1,880 -67.9%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type